X4 Pharmaceuticals (XFOR)
(Delayed Data from NSDQ)
$0.60 USD
0.00 (-0.73%)
Updated Feb 4, 2025 04:00 PM ET
After-Market: $0.60 0.00 (0.72%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 3/20/25 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.18 |
Last EPS Surprise | -5.88% |
ABR | 1.00 |
Earnings ESP
|
8.05% |
---|---|
Current Year | -0.16 |
Next Year | -0.59 |
EPS (TTM) | -0.61 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.96M | 1.44M | 2.09M | 15.16M |
# of Estimates | 5 | 2 | 5 | 5 |
High Estimate | 1.35M | 1.48M | 2.47M | 20.00M |
Low Estimate | 0.70M | 1.40M | 1.87M | 7.81M |
Year ago Sales | 0.00M | 0.00M | NA | 2.09M |
Year over Year Growth Est. | NA | NA | NA | 624.47% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.16 | -0.16 | -0.59 |
# of Estimates | 5 | 2 | 5 | 5 |
Most Recent Consensus | -0.16 | -0.15 | -0.15 | -0.78 |
High Estimate | -0.16 | -0.15 | -0.14 | -0.41 |
Low Estimate | -0.19 | -0.17 | -0.17 | -0.78 |
Year ago EPS | -0.10 | -0.26 | -0.57 | -0.16 |
Year over Year Growth Est. | -70.00% | 38.46% | 71.93% | -267.50% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.16 | -0.16 | -0.59 |
7 Days Ago | -0.17 | -0.16 | -0.16 | -0.59 |
30 Days Ago | -0.17 | -0.16 | -0.15 | -0.45 |
60 Days Ago | -0.17 | -0.16 | -0.24 | -0.42 |
90 Days Ago | -0.16 | -0.16 | -0.22 | -0.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | -0.16 | -0.15 | -0.78 |
Zacks Consensus Estimate | -0.17 | -0.16 | -0.16 | -0.59 |
Earnings ESP | 8.05% | 0.00% | 5.06% | -33.11% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.18 | -0.07 | -0.26 | -0.10 | NA |
Estimate | -0.17 | -0.05 | -0.17 | -0.15 | NA |
Difference | -0.01 | -0.02 | -0.09 | 0.05 | -0.02 |
Surprise | -5.88% | -40.00% | -52.94% | 33.33% | -16.37% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more